The global life science logistics market is poised for significant expansion, projected to grow from USD 19.1 billion in 2025 to USD 41.3 billion by 2035, at a compound annual growth rate (CAGR) of 8%. This growth is being fueled by rising demand for specialized logistics solutions in pharmaceuticals, biotechnology, and medical devices, alongside rapid advancements in cold chain management and temperature-controlled transportation.
Quick Stats for Life Science Logistics Market
Industry Value (2025): USD 19.1 billion
Industry Forecast Value (2035): USD 41.3 billion
Forecast CAGR: 8%
Leading Segment: Pharmaceutical Companies (55% share)
Key Growth Region: Asia Pacific (India)
Key Players: DHL, World Courier, Quick STAT, CEVA Logistics, Marken
Warehousing and Storage Services to Lead Life Science Logistics by Service Type in 2025
Warehousing and storage services are expected to account for 50% of the market in 2025, reflecting their critical role in safeguarding temperature-sensitive products like biologics, vaccines, and pharmaceuticals. Advanced temperature-controlled facilities, security measures, and real-time inventory tracking are now standard in global distribution hubs. Regulatory compliance and adaptability in managing global supply chains remain top priorities, particularly as biologics and vaccines drive new storage requirements.
Click Here for More Information:-
https://www.futuremarketinsights.com/reports/life-science-logistics-market
Pharmaceuticals Expected to Dominate Life Science Logistics Applications with 45% Share in 2025
Pharmaceutical logistics will lead with a 45% share in 2025, driven by the urgent need for secure and compliant handling of high-value medications. The sector demands specialized cold chain transportation, advanced tracking, and packaging solutions to preserve product integrity from production to delivery. With the surge in biologics and vaccine manufacturing, logistics complexity is increasing, prompting providers to invest in automated, IoT-enabled monitoring systems.
Pharmaceutical Companies Lead the End-User Segment with 55% Industry Share in 2025
Pharmaceutical companies will hold a dominant 55% share in the life science logistics market by 2025. As global demand for drugs and biologics rises, manufacturers depend heavily on precise logistics operations to ensure timely, compliant, and temperature-controlled deliveries. Emerging markets, especially in Asia Pacific, are amplifying demand for sophisticated supply chain solutions, bolstered by expanding manufacturing hubs and export capacity.
Rising Demand for Temperature-Sensitive Life Science Products
The market’s momentum is underpinned by an increase in chronic diseases, a shift toward biologic therapies, and the growing scale of global clinical trials. Advances such as automated cold storage, IoT tracking, and predictive analytics are enhancing delivery reliability. Real-time temperature monitoring is becoming standard, ensuring regulatory compliance and safeguarding product quality.
Challenges Hindering Growth in the Life Science Logistics Industry
Despite strong growth potential, the industry faces headwinds from escalating transportation costs, stringent regulations, and the complexity of temperature-controlled shipments. Rising fuel prices, carrier capacity constraints, and varying regional compliance frameworks present ongoing challenges. Meeting these demands requires investment in infrastructure, staff training, and digital monitoring capabilities.
Country-Wise Analysis of Life Science Logistics Market
Among major markets, India leads with a forecast CAGR of 9.2%, driven by pharmaceutical exports and cold chain infrastructure expansion. China follows at 8.5%, fueled by vaccine and biosimilar production. The United States records 7.5%, supported by FDA-aligned cold chain modernization. Japan maintains 7.2% growth through advanced compliance systems, while the United Kingdom posts 6.7%, reflecting a more mature market.
Leading Life Science Logistics Market Suppliers
DHL dominates with a 30% market share, leveraging extensive R&D, global warehousing, and specialized temperature-controlled fleets. World Courier, Quick STAT, and CEVA Logistics remain prominent, with emerging players such as Rhenus Group and MNX Global Logistics focusing on cost-effective, tech-driven solutions.
Recent Life Science Logistics Industry Developments
In April 2025, UPS announced a USD 1.6 billion acquisition of Andlauer Healthcare Group, strengthening its temperature-controlled logistics capacity. In March 2025, DHL acquired CryoPDP to enhance its pharma sector capabilities, further solidifying its role in complex supply chain management.
Get Sample Report: -
https://www.futuremarketinsights.com/reports/sample/rep-gb-22322
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analystsworldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website:
https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
The global life science logistics market is poised for significant expansion, projected to grow from USD 19.1 billion in 2025 to USD 41.3 billion by 2035, at a compound annual growth rate (CAGR) of 8%. This growth is being fueled by rising demand for specialized logistics solutions in pharmaceuticals, biotechnology, and medical devices, alongside rapid advancements in cold chain management and temperature-controlled transportation.
Quick Stats for Life Science Logistics Market
Industry Value (2025): USD 19.1 billion
Industry Forecast Value (2035): USD 41.3 billion
Forecast CAGR: 8%
Leading Segment: Pharmaceutical Companies (55% share)
Key Growth Region: Asia Pacific (India)
Key Players: DHL, World Courier, Quick STAT, CEVA Logistics, Marken
Warehousing and Storage Services to Lead Life Science Logistics by Service Type in 2025
Warehousing and storage services are expected to account for 50% of the market in 2025, reflecting their critical role in safeguarding temperature-sensitive products like biologics, vaccines, and pharmaceuticals. Advanced temperature-controlled facilities, security measures, and real-time inventory tracking are now standard in global distribution hubs. Regulatory compliance and adaptability in managing global supply chains remain top priorities, particularly as biologics and vaccines drive new storage requirements.
Click Here for More Information:- https://www.futuremarketinsights.com/reports/life-science-logistics-market
Pharmaceuticals Expected to Dominate Life Science Logistics Applications with 45% Share in 2025
Pharmaceutical logistics will lead with a 45% share in 2025, driven by the urgent need for secure and compliant handling of high-value medications. The sector demands specialized cold chain transportation, advanced tracking, and packaging solutions to preserve product integrity from production to delivery. With the surge in biologics and vaccine manufacturing, logistics complexity is increasing, prompting providers to invest in automated, IoT-enabled monitoring systems.
Pharmaceutical Companies Lead the End-User Segment with 55% Industry Share in 2025
Pharmaceutical companies will hold a dominant 55% share in the life science logistics market by 2025. As global demand for drugs and biologics rises, manufacturers depend heavily on precise logistics operations to ensure timely, compliant, and temperature-controlled deliveries. Emerging markets, especially in Asia Pacific, are amplifying demand for sophisticated supply chain solutions, bolstered by expanding manufacturing hubs and export capacity.
Rising Demand for Temperature-Sensitive Life Science Products
The market’s momentum is underpinned by an increase in chronic diseases, a shift toward biologic therapies, and the growing scale of global clinical trials. Advances such as automated cold storage, IoT tracking, and predictive analytics are enhancing delivery reliability. Real-time temperature monitoring is becoming standard, ensuring regulatory compliance and safeguarding product quality.
Challenges Hindering Growth in the Life Science Logistics Industry
Despite strong growth potential, the industry faces headwinds from escalating transportation costs, stringent regulations, and the complexity of temperature-controlled shipments. Rising fuel prices, carrier capacity constraints, and varying regional compliance frameworks present ongoing challenges. Meeting these demands requires investment in infrastructure, staff training, and digital monitoring capabilities.
Country-Wise Analysis of Life Science Logistics Market
Among major markets, India leads with a forecast CAGR of 9.2%, driven by pharmaceutical exports and cold chain infrastructure expansion. China follows at 8.5%, fueled by vaccine and biosimilar production. The United States records 7.5%, supported by FDA-aligned cold chain modernization. Japan maintains 7.2% growth through advanced compliance systems, while the United Kingdom posts 6.7%, reflecting a more mature market.
Leading Life Science Logistics Market Suppliers
DHL dominates with a 30% market share, leveraging extensive R&D, global warehousing, and specialized temperature-controlled fleets. World Courier, Quick STAT, and CEVA Logistics remain prominent, with emerging players such as Rhenus Group and MNX Global Logistics focusing on cost-effective, tech-driven solutions.
Recent Life Science Logistics Industry Developments
In April 2025, UPS announced a USD 1.6 billion acquisition of Andlauer Healthcare Group, strengthening its temperature-controlled logistics capacity. In March 2025, DHL acquired CryoPDP to enhance its pharma sector capabilities, further solidifying its role in complex supply chain management.
Get Sample Report: - https://www.futuremarketinsights.com/reports/sample/rep-gb-22322
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analystsworldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube